Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Investigating anticarcinogenic compounds as an alternative to chemo

Dr Bernardo Bonnani - European Institute of Oncology, Milan, Italy

Investigating anticarcinogenic compounds as an alternative to chemo ( Dr Bernardo Bonnani - European Institute of Oncology, Milan, Italy )

ASCO 2014 roundup

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

ASCO 2014 roundup ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )

Adding lapatinib to adjuvant trastuzumab does not improve outcomes in early...

Dr Edith Perez - Mayo Clinic, Rochester, USA

Adding lapatinib to adjuvant trastuzumab does not improve outcomes in early- stage HER2-positive breast cancer ( Dr Edith Perez - Mayo Clinic, Rochester, USA )

Adding lapatinib to adjuvant trastuzumab does not improve outcomes in early...

Dr Edith Perez - Mayo Clinic, Rochester, USA

Adding lapatinib to adjuvant trastuzumab does not improve outcomes in early-stage HER2-positive breast cancer ( Dr Edith Perez - Mayo Clinic, Rochester, USA )

Adjuvant exemestane more effective than tamoxifen when combined with ovarian...

Dr Olivia Pagani - Oncology Institute of Southern Switzerland, Bellinzona...

Adjuvant exemestane more effective than tamoxifen when combined with ovarian function suppression in young women with hormone-sensitive, early-stage breast cancer ( Dr Olivia Pagani - Oncology Institute of Southern Switzerland, Bellinzona, Switzerland )

Adjuvant exemestane is more effective than tamoxifen when combined with ovarian...

Dr Olivia Pagani - Oncology Institute of Southern Switzerland, Bellinzona...

Adjuvant exemestane is more effective than tamoxifen when combined with ovarian function suppression in young women with hormone-sensitive, early-stage breast cancer ( Dr Olivia Pagani - Oncology Institute of Southern Switzerland, Bellinzona, Switzerland )

Comment: Advances in breast cancer presented at ASCO 2014

Prof Jacek Jassem - Gdańsk Medical University, Gdańsk, Poland

Comment: Advances in breast cancer presented at ASCO 2014 ( Prof Jacek Jassem - Gdańsk Medical University, Gdańsk, Poland )

Vitamin D as a prevention against breast cancer

Dr Song Yao - Roswell Cancer Center Institute, New York, USA

Vitamin D as a prevention against breast cancer ( Dr Song Yao - Roswell Cancer Center Institute, New York, USA )

Subset of breast cancer patients found to benefit from neratinib in latest trial

Dr John W. Park - University of California San Francisco, San Francisco, USA

Subset of breast cancer patients found to benefit from neratinib in latest trial ( Dr John W. Park - University of California San Francisco, San Francisco, USA )

"Exciting" implications of bemacyclib study in the treatment of breast cancer

Dr Amita Patnaik - South Texas Accelerated Research Therapeutics, San Antonio...

"Exciting" implications of bemacyclib study in the treatment of breast cancer ( Dr Amita Patnaik - South Texas Accelerated Research Therapeutics, San Antonio, USA )

Role of AORTIC in dealing with rising cancer rates in Africa

North American Vice president of AORTIC

Role of AORTIC in dealing with rising cancer rates in Africa ( North American Vice president of AORTIC )

Study identifies new strategy to overcome breast cancer resistance to HER2...

Dr Joan Garrett - Vanderbilt University Medical Center, Nashville, USA

Study identifies new strategy to overcome breast cancer resistance to HER2-targeted therapies ( Dr Joan Garrett - Vanderbilt University Medical Center, Nashville, USA )

More from ecancer